BRIEF published on 09/26/2025 at 14:50, 9 months 17 days ago EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
PRESS RELEASE published on 09/26/2025 at 14:45, 9 months 17 days ago enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRIEF published on 09/15/2025 at 14:50, 9 months 28 days ago EnVVeno Medical dépose un recours auprès de la FDA EnVVeno Medical Insuffisance Veineuse Chronique Valve VenoValve Appel Auprès De La FDA Processus Réglementaire
BRIEF published on 09/15/2025 at 14:50, 9 months 28 days ago EnVVeno Medical Pursues FDA Supervisory Appeal EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
PRESS RELEASE published on 09/15/2025 at 14:45, 9 months 28 days ago enVVeno Medical Updates Regulatory Status of VenoValve(R) enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal
BRIEF published on 08/20/2025 at 13:05, 10 months 24 days ago EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve EnVVeno Medical VenoValve FDA Decision Deep Venous Disease Premarket Approval
BRIEF published on 08/20/2025 at 13:05, 10 months 24 days ago EnVVeno Medical reçoit une lettre de non-approbation de la FDA pour VenoValve EnVVeno Medical Valve VenoValve Décision De La FDA Maladie Veineuse Profonde Approbation Préalable À La Mise Sur Le Marché
PRESS RELEASE published on 08/20/2025 at 13:00, 10 months 24 days ago enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) enVVeno Medical received a not-approvable letter from the FDA for VenoValve, citing lacking hemodynamic data and safety concerns. Company to work on new criteria and potential resubmission FDA Medical Device EnVVeno Medical VenoValve CVI
BRIEF published on 08/15/2025 at 15:26, 10 months 29 days ago EnVVeno Medical participera à la série de webinaires financiers Webull EnVVeno Medical Valve VenoValve Maladie Veineuse Profonde Webull Financial Biotechnologie/Technologie Médicale
BRIEF published on 08/15/2025 at 15:26, 10 months 29 days ago EnVVeno Medical to Present at Webull Financial Webinar Series EnVVeno Medical VenoValve Deep Venous Disease Webull Financial Biotech/MedTech
Published on 07/14/2026 at 01:45, 1 hour 54 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 3 hours 38 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 4 hours 29 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 6 hours 4 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 7 hours 39 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 22:30, 5 hours 9 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 6 hours 19 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 6 hours 21 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 6 hours 51 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 7 hours 16 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 9 hours 39 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 9 hours 39 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 9 hours 39 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
